TherapeuticsMD (United States)

Recent papers from TherapeuticsMD (United States)

1. Remarkable response of metaplastic breast cancer to a novel targeted AKT inhibitor TAS-117 in a Cowden syndrome patient: a case reportBJC Reports · 2026
2. Novel Clinical Trial Designs for Intermediate Age-Related Macular DegenerationOphthalmology Science · 2026
3. A drug-drug interaction study to evaluate the effects of strong CYP3A4 inducer on the pharmacokinetics of segesterone acetate and ethinyl estradiol in a contraceptive vaginal systemContraception and Reproductive Medicine · 2025
4. Abstract A005: Novel glycoproteomic biomarkers for early detection of ovarian cancerCancer Research · 2025
5. Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancersCell Reports Medicine · 2025
6. Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer’s disease2024
7. Validation of an ICD‐10 case‐finding algorithm for endometrial cancer in US insurance claimsPharmacoepidemiology and Drug Safety · 2023
8. Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring UsersJournal of Women s Health · 2023
9. Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestinsGynecological Endocrinology · 2022
10. Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insertMenopause The Journal of The North American Menopause Society · 2021
11. Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal systemContraception · 2021
12. Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and MetastasisCancer Research · 2020
13. Determinants of attained estradiol levels in response to oral estradiol plus progesterone therapyClimacteric · 2020
14. Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trialMenopause The Journal of The North American Menopause Society · 2020
15. Uterine bleeding with hormone therapies in menopausal women: a systematic reviewClimacteric · 2020
16. Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinionExpert Opinion on Drug Delivery · 2020
17. Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist PerspectivePharmacy · 2020
18. Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trialMenopause The Journal of The North American Menopause Society · 2020
19. 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trialMenopause The Journal of The North American Menopause Society · 2020
20. TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trialMenopause The Journal of The North American Menopause Society · 2020